Literature DB >> 14678981

Enhanced ubiquitinylation of heat shock protein 90 as a potential mechanism for mitotic cell death in cancer cells induced with hypericin.

Michael Blank1, Mathilda Mandel, Yona Keisari, Daniel Meruelo, Gad Lavie.   

Abstract

A unique property of the photodynamic signal transduction inhibitor hypericin is functionality in the dark. We show in tumor cells that hypericin targets the heat shock protein (Hsp) 90 chaperone but not Hsp70 (Hsc70) to enhanced ubiquitinylation. As a consequence Hsp90 chaperone functionality is abrogated and the client proteins, mutant p53, Cdk4, Raf-1, and Plk, are displaced from complexes with Hsp90, destabilized, and degraded via a proteasome-independent pathway. Decline in Raf-1 prevents downstream activation of extracellular signal-regulated kinase 1/2 kinases, the Ras/Raf pathway is inhibited, and tumor cell proliferation is arrested. The cells exhibit multiple aberrations including retardation at G(2)-M, increased cell volume, and multinucleation, all of which are hallmarks of mitotic cell death. The studies demonstrate that ubiquitinylation of Hsp90 inactivates the chaperone, destabilizes the plethora of client proteins, and creates deficiencies in multiple unrelated cellular functions. This combination constitutes a mechanism by which hypericin generates mitotic cell death in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14678981

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Alternative approaches to Hsp90 modulation for the treatment of cancer.

Authors:  Jessica A Hall; Leah K Forsberg; Brian S J Blagg
Journal:  Future Med Chem       Date:  2014-09       Impact factor: 3.808

2.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-03       Impact factor: 3.631

3.  Glutathione protects cells against arsenite-induced toxicity.

Authors:  Geetha M Habib; Zheng-Zheng Shi; Michael W Lieberman
Journal:  Free Radic Biol Med       Date:  2006-10-12       Impact factor: 7.376

Review 4.  Post-translational modifications of Hsp90 and their contributions to chaperone regulation.

Authors:  Mehdi Mollapour; Len Neckers
Journal:  Biochim Biophys Acta       Date:  2011-08-10

5.  Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.

Authors:  Mark J de Keijzer; Daniel J de Klerk; Lianne R de Haan; Robert T van Kooten; Leonardo P Franchi; Lionel M Dias; Tony G Kleijn; Diederick J van Doorn; Michal Heger
Journal:  Methods Mol Biol       Date:  2022

6.  p53 regulates Hsp90beta during arsenite-induced cytotoxicity in glutathione-deficient cells.

Authors:  Geetha M Habib
Journal:  Arch Biochem Biophys       Date:  2008-10-26       Impact factor: 4.013

7.  Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated.

Authors:  Soo-Yeon Park; Young Mee Kim; Hongryull Pyo
Journal:  Mol Cancer       Date:  2010-08-23       Impact factor: 27.401

Review 8.  Hsp90, an unlikely ally in the war on cancer.

Authors:  Jared J Barrott; Timothy A J Haystead
Journal:  FEBS J       Date:  2013-02-24       Impact factor: 5.542

9.  Alterations in dysadherin expression and F-actin reorganization: a possible mechanism of hypericin-mediated photodynamic therapy in colon adenocarcinoma cells.

Authors:  Aysun Kılıç Süloğlu; Güldeniz Selmanoğlu; M Turan Akay
Journal:  Cytotechnology       Date:  2014-02-08       Impact factor: 2.058

Review 10.  Tumor-intrinsic and tumor-extrinsic factors impacting hsp90- targeted therapy.

Authors:  S V Alarcon; M Mollapour; M-J Lee; S Tsutsumi; S Lee; Y S Kim; T Prince; A B Apolo; G Giaccone; W Xu; L M Neckers; J B Trepel
Journal:  Curr Mol Med       Date:  2012-11-01       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.